Stock NRX NUREXONE BIOLOGIC INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NurExone Biologic Inc.

Equities

NRX

CA67059R1091

Market Closed - Toronto S.E.
Other stock markets
 03:32:51 2024-07-08 pm EDT 		5-day change 1st Jan Change
0.7 CAD 0.00% Intraday chart for NurExone Biologic Inc. +6.06% +137.29%
Jun. 28 NurExone Biologic Inc. Announces Pre-Clinical Study to Explore the Potential of NurExone's Exosome-Based Therapies in Regenerating Damaged Optic Nerves CI
May. 29 NurExone Biologic Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on NurExone Biologic Inc.

Price target over the last 5 years

History of analyst recommendation changes

1d.YX11AqOVFEIFELkpcmaMs5GRf_5-xstvtv8W6InN5-I.Lkwdb8z5LQhmc-p7GBe_h_CgILUzo78f07dyrOKGpLogRDpk4aYmE0cjjQ~9160ae81fee47e8782f7a0e1392edb79

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5134 USD
Average target price
2.918 USD
Spread / Average Target
+468.33%
High Price Target
2.918 USD
Spread / Highest target
+468.33%
Low Price Target
2.918 USD
Spread / Lowest Target
+468.33%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NRX Stock
  4. Consensus NurExone Biologic Inc.